R ecuRRent lumbar disc herniation (RLDH) is a significant cause of morbidity in patients undergoing lumbar discectomy as it may occur in 5%-18% of patients. 3, 5, 11 RLDH is thought to represent surgical failure, 2, 8, 10 and multiple studies have examined which demographic and operative factors might contribute to its occurrence. 12, 14, 16 Whether repeat discectomy or posterior instrumented fusion offers the best management for patients with recurrent disc herniation is a controversial topic. Repeat discectomy is often successful in treating these patients, but concern over repeat RLDH may lead many surgeons to advocate instrumented fusion in the absence of instability. To our knowledge, there are no direct comparisons of clinical outcomes and hospital charges for these patients in the literature.
Neurosurgery Quality and Outcomes Database (N 2 QOD). N 2 QOD is a national clinical registry that enables the prospective collection of data for a variety of neurosurgical conditions to facilitate studies promoting improvements in quality and outcomes. 13 We hypothesized that patient-reported outcomes are similar between the two procedures but that length of surgery, length of hospital stay, and disposition status vary between the two.
Methods

Study Population
After obtaining approval from the institutional review board, we queried the N 2 QOD to obtain information about patients who underwent repeat discectomy or instrumented fusion for a diagnosis of recurrent herniated nucleus pulposus (ipsilateral or contralateral) at a single institution between November 2012 and May 2015. Eligible patients were 18 years or older and had at least 12 months of follow-up postoperatively.
Preoperative evaluation
The decision about which treatment modality to use was based on a variety of clinical and radiographic variables and depended on the discretion of the operating surgeon. Preoperative MRI with and without contrast was performed prior to surgery in all cases to confirm that recurrent disc herniation and not scar tissue or other abnormality was the cause of patient's symptoms.
Postoperative Care
All patients were encouraged to begin ambulating on postoperative Day 1. All patients were seen and evaluated by the physical and occupational therapy team. Pain management was based on patient and treating physician preference. Discharge decisions were made in collaboration with the patient, the surgical team, the therapy team, and, when needed, the rehabilitation service. Prior to discharge home, all patients had to pass a physical therapy-administered home safety evaluation, demonstrate the ability to tolerate adequate oral intake, and have their pain well controlled utilizing oral pain medications alone.
Data Collection
We collected demographic and relevant medical history data, including sex, age, ethnicity (dichotomized into Caucasian and other), body mass index, tobacco use, American Society of Anesthesiologists (ASA) Physical Status Classification System (ASA class), education level, employment status, and presence of diabetes and/or hypertension. Preoperative data included predominant symptom (pain, weakness, or numbness), workers' compensation claim status, instability (as defined by motion on flexion/extension radiographs), Modic changes on preoperative MRI, preoperative listhesis, recurrence number (dichotomized into the first recurrence or later recurrences), time in years between the initial discectomy and the repeat surgery, and symptom duration. Primary outcomes included back and leg pain visual analog scale (VAS) scores, EuroQol (EQ)-VAS score, quality-adjusted life year (QALY), and Oswestry Disability Index (ODI) score at the 3-month follow-up. Secondary operative and perioperative outcomes data included length of surgery, length of stay, discharge destination, complication rates, and hospital charges. Secondary postoperative outcomes data included the ability to return to work within a year postoperatively, reoperation rates at follow-up and 12-month assessments of leg pain VAS score, back pain VAS score, EQ-VAS score, QALY, and ODI. Finally, for the instrumented fusion group, we evaluated fusion rates at the 12-month follow-up, defined as lack of motion on flexion/extension radiographs and/or bony bridging.
Statistical analysis
Patients were separated into 2 groups based on whether they had repeat discectomy or posterior instrumented fusion for all analyses. Continuous variables were compared using the Student t-test, and categorical variables were compared using chi-square analysis. Significance was defined in all cases as p < 0.05. All calculations were performed using SPSS (IBM Corp.).
results
We identified 25 patients who underwent repeat discectomy and 12 patients who underwent lumbar fusion for treatment of RLDH between November 2012 and May 2015 and satisfied inclusion criteria for analysis. Within the fusion group, patients underwent various types of surgery based on surgeon preference and surgical variables: 7 patients underwent a transforaminal lumbar interbody fusion, 3 had a minimally invasive transforaminal lumbar interbody fusion, and 2 underwent a posterior lumbar interbody fusion. A combination of autograft, allograft, and polyetheretherketone (PEEK) was used in 3 patients, PEEK and autograft were used in 2, autograft and allograft were used in 4, and PEEK, autograft, or allograft alone in 1 patient each. Patients treated with repeat discectomy and lumbar fusion had similar demographic characteristics including age, employment status, education level, body mass index, tobacco use, rates of diabetes, rates of hypertension, and race/ethnicity. Patients in the instrumented fusion group were significantly more likely to be female (58% vs 20%, p = 0.020; Table 1 ). The ASA classes for the groups were not significantly different, with the majority of patients falling into ASA Class II (mild systemic disease). The predominant presenting symptom in both groups was numbness or pain, and the majority of patients had symptoms lasting 3 months or longer. Patients involved in workers' compensation claims made up a minority in both groups. The mean time between initial/ previous discectomy and repeat procedure was 6.0 ± 6.7 years for the repeat discectomy group and 3.4 ± 3.9 years for the fusion group, and this difference was not statistically significant (p = 0.224). Preoperative patient-reported outcomes, including ODI, VAS (back and leg), and EQ-VAS scores and QALY, were similar between the groups. No patient demonstrated radiographic instability prior to surgery in either group. Modic changes were seen in 56% of repeat discectomy patients and 25% of fusion patients, a difference that was not statistically significant (p = 0.077).
Rates of preoperative listhesis were also similar between the groups. Patients in the repeat discectomy group were more likely to be receiving treatment for their first RLDH than those in the fusion group (88% vs 75%), but this difference also was also not statistically significant (p = 0.315).
The mean follow-up duration was 2.2 ± 0.75 years for the repeat discectomy group (range 1.0-3.4 years) and 2.2 ± 0.69 years for the instrumented fusion group (range 1.2-3.2 years). Three-month follow-up data for ODI were available for all 37 patients, and the remaining primary outcomes data were available for 95% or more of patients ( Table 2 ). All patient-reported outcomes were similar in the 2 groups at both the 3-and 12-month follow-ups. For our primary outcomes, the mean ODI score at 3 months was 11.9 ± 8.9 in the repeat discectomy group and 13.1 ± 9.3 in the fusion group. The mean 3-month back and leg pain VAS scores were 3.0 ± 3.1 and 2.6 ± 2.3, respectively, in the repeat discectomy group and 3.6 ± 2.4 and 2.8 ± 2.6, respectively, in the fusion group. The mean QALY at 3 months was 0.74 ± 0.24 in the repeat discectomy group and 0.70 ± 0.19 in the fusion group. None of these differences was statistically significant (p ≥ 0.05). There were no significant differences in rates of complications between the discectomy and the fusion groups, with dural tears being the only adverse event and occurring in 2 patients in each group (p = 0.43).
For our secondary outcomes, 12-month patient-reported outcomes data were available in at least 33 of 37 cases (89%) for all outcomes: 22 (88%) in the repeat discectomy group and 11 (92%) in the instrumented fusion group. There were no significant differences in any of our 4 patient-reported outcomes between the repeat discectomy and instrumented fusion groups at the 12-month follow-up. Patients in the repeat discectomy group had a significantly shorter length of stay than those in the instrumented fusion group (1.0 ± 0.3 days vs 3.7 ± 0.9 days, p < 0.001) and had significantly shorter operative times (82.7 ± 29.1 minutes vs 229.6 ± 42.1 minutes, p < 0.001) ( Table 3) . Patients in the repeat discectomy group were also significantly more likely to be able to discharge home (100% vs 83%, p = 0.036). Three patients in the repeat discectomy group (12%) needed additional repeat surgery by the time of last follow-up because of repeat RLDH, while none in the instrumented fusion group needed reoperation; this differ- 
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ence was not significant (p = 0.211). Hospital charges were significantly higher for the fusion group than the repeat discectomy group ($54,458.29 ± $6160.29 vs $11,567.05 ± $2937.44, p < 0.001). Of the 12 patients who underwent instrumented fusion, 11 (92%) showed radiographic evidence of fusion at the 12-month follow-up. Of the patients who were working or employed but not working at the time of surgery, 89% of patients in the repeat discectomy group were able to return to work within 12 months, while 75% of the fusion group did so. This difference was not statistically significant (p = 0.464).
Discussion
Despite the relatively high prevalence of RLDH after lumbar discectomy, its management 17 and even its definition-whether to include both ipsilateral and contralateral reherniations 7 and the specific window of time after which a disc herniation may be considered recurrent versus a simple failure of the original surgery 1 -are the subjects of debate. The controversies are propagated by a lack of high-quality evidence comparing repeat discectomy and instrumented fusion head to head. 4 Our study contributes to the understanding of optimal management for RLDH by examining a multitude of patient-reported and clinical outcomes in addition to hospital charges for the 2 preferred forms of intervention. Data for our study were obtained through the N 2 QOD database. Patient-reported outcomes at both the 3-and 12-month follow-ups were similar in the 2 treatment groups. These findings support those from existing literature suggesting that both surgical interventions for RLDH are efficacious. 6 Operative time, length of stay, rates of discharge to acute rehabilitation, and hospital charges, however, were all significantly higher in the instrumented fusion group than in the repeat discectomy group. Patients undergoing fusion were also more likely to be female. The cause for this difference is not definitively identifiable based on our study, although differential satisfaction with lumbar spine procedures between men and women has been reported in the literature, 15 and it is possible that women were more likely to elect for a different procedure after an initial failed discectomy as a result.
Despite these findings, it remains difficult to define the optimal intervention for RLDH. Although length of stay was longer in the fusion cohort, the average hospitalization duration for this group was less than 4 days. Similarly, although discharge to acute rehabilitation was needed in a higher proportion of fusion patients than repeat discectomy patients, the vast majority of fusion patients-more than 80%-were able to return home postoperatively.
Our study has several limitations. The first is its retrospective nature, although the utilization of the prospectively acquired N 2 QOD database likely ameliorates this to some degree. Our study data are drawn from a single center and our sample size is limited, thus limiting both the generalizability of our findings and raising the distinct possibility that our cohort is underpowered to find a sig- nificant difference in our patient-reported outcomes. Indeed, based on previous publications, 4, 6 thousands of cases would need to be analyzed to have an appropriately powered study comparing these treatments. The data for these studies themselves are generally gleaned from small, retrospective case series, however, and significant questions remain as to the magnitude of difference in outcome between repeat discectomy and fusion for RLDH.
Despite our limited power, we believe that our study highlights an important facet of the N 2 QOD initiative. The primary purpose of the N 2 QOD (http://www.neuropoint. org/NPA%20N2QOD.aspx) is to "establish risk-adjusted national benchmarks for both the cost and quality of common neurosurgical procedures," and we believe that in the future such databases will allow for significant advancement of our knowledge on vital surgery-related outcomes. The second stated goal of the N 2 QOD, however, is to "allow practice groups and hospitals to analyze their individual morbidity and clinical outcomes in real time." Although our data set is limited to our institution, our findings demonstrate significant differences in individual-level and hospital-level outcomes, specifically, the significantly longer operative time, length of stay, and need for rehabilitation among patients undergoing fusion compared with those undergoing repeat discectomy. These data will allow us to better counsel our patients, and we believe this study highlights the utility of the N 2 QOD as an agile, scalable resource rather than just a monolithic "big data" tool. Even though our findings are not necessarily surprising given the nature of the 2 surgical interventions, the magnitude of the differences between these procedures has previously not been investigated using a database such as the N 2 QOD. For our institution, until March 1, 2015, the first 6 patients who met inclusion criteria each week were enrolled in the lumbar N 2 QOD module. It is possible, therefore, that some patients with recurrent disc herniation were missed as a result, but if this is the case, we expect that any missed patients were done so at random and would not dramatically bias our results. Beginning March 1, 2015, all patients meeting the criteria for inclusion were enrolled. During the study period, 471 microdiscectomies were performed at our institution, for a recurrent disc herniation rate of 7.9%. This is fairly consistent with previously published rates, and we believe it suggests that the majority of recurrent cases were captured in our cohort. 3, 5, 11 Nevertheless, the possibility of missed cases is a significant limitation.
Twelve percent of the repeat discectomy patients in our group required reoperation in the follow-up period (Fig.  1 ), whereas none of the patients within the fusion group required another surgery. This difference was not statistically significant, however, and because of the relatively short follow-up period in our cohort and our small sample size, such a finding should be interpreted cautiously. At most, this suggests that a larger study involving multiple centers is needed to better define the true rate of reoperation within these 2 groups. Finally, the popularization of minimally invasive approaches to both primary and repeat discectomies 9 may change the surgical profile of repeat disc surgery, and investigations into the utilization and outcomes of these techniques are needed.
Conclusions
For patients experiencing RLDH, repeat discectomy and instrumented fusion resulted in similar patient-reported outcomes on short-term follow-up. Repeat discectomy may offer multiple short-term benefits compared with instrumented fusion, but with such similarities in outcomes observed in our study, the choice of which surgery to offer must be individualized for each patient's specific needs and characteristics.
